Approved for GLASSIA is an Alpha 1 -Proteinase Inhibitor (Human), indicated for chronic augmentation and maintenance therapy in individuals with clinically evident emphysema due to severe hereditary deficiency of Alpha 1 -PI, also known as alpha 1 -antitrypsin (AAT) deficiency. Limitations of Use : The effect of augmentation therapy with GLASSIA or any Alpha 1 -PI product on pulmonary…
Loading full data from Know Your Drugs Institute…